Detalhe da pesquisa
1.
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.
Blood
; 140(16): 1816-1821, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853156
2.
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase.
Haematologica
; 109(4): 1082-1094, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941406
3.
Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors.
Bioorg Med Chem Lett
; 23(24): 6610-5, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239188
4.
Preparation and crystallization of riboswitch-ligand complexes.
Methods Mol Biol
; 540: 115-28, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19381556
5.
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN.
Leukemia
; 34(4): 1197-1201, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719682
6.
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
J Med Chem
; 56(20): 7772-87, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24083782
7.
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
J Med Chem
; 56(20): 7788-803, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24093940
8.
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
Mol Cancer Ther
; 10(11): 2104-14, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21878655
9.
Ribosomal protein S15 represses its own translation via adaptation of an rRNA-like fold within its mRNA.
EMBO J
; 22(8): 1898-908, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12682022